课题基金 / 基金详情

Mechanisms of lipid-induced bioenergetic stress in muscle

Mechanisms of lipid-induced bioenergetic stress in muscle
脂质诱导肌肉生物能应激的机制
批准号:
10409823
负责人:
DEBORAH M MUOIO
金额:
$59.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
未结题
起止时间:
2010-07-01 至 2025-05-31
关键词:
ATP HydrolysisAcuteAcyl Coenzyme AAgeAgingAreaBioenergeticsBiological AssayBiological MarkersBloodBlood GlucoseButyratesCarbonCardiacCardiometabolic DiseaseCatabolic ProcessCatabolismClinicalComplexConsumptionDiabetes MellitusDiagnosticDiseaseElectron TransportElectronsEnergy MetabolismEnergy TransferEnzymesEventExercise ToleranceExercise stress testFastingFatty AcidsFree EnergyFunctional disorderGrantHealthHeartHeart MitochondriaHeart failureHereditary DiseaseHomeostasisHumanImpairmentIn VitroInstitutesIntermittent fastingKetonesKineticsLaboratoriesLinkLipidsMass Spectrum AnalysisMediator of activation proteinMembrane PotentialsMetabolicMetabolic DiseasesMetabolic stressMetabolismMethodsMitochondriaMitochondrial DiseasesMitochondrial ProteinsModelingMole the mammalMolecularMolecular ProfilingMusMuscleMuscle MitochondriaMyocardial dysfunctionNatural regenerationNon-Insulin-Dependent Diabetes MellitusNormal CellNutrientObesityOrganOrgan failureOutcomeOxidation-ReductionOxidoreductasePathway interactionsPhosphorylationPhysiologicalPhysiologyPlayPopulationPost-Translational Protein ProcessingPotential EnergyPrediabetes syndromeProcessProteomicsRegimenReportingResearch PersonnelResistanceRoleRouteSignal TransductionSkeletal MuscleStressStress TestsTechnologyTestingThermodynamicsTissuesWorkacylcarnitineage relatedbasecancer cachexiacardiometabolismdiagnostic assaydiagnostic platformexercise intolerancefatty acid oxidationinsightlong chain fatty acidmetabolomicsmitochondrial dysfunctionmultiple omicsmultiplex assaynovel therapeutic interventionnutrition related geneticsoxidationphosphoproteomicsrespiratoryresponsestemtool

项目摘要

项目成果

DEBORAH M MUOIO的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Abstract Our work in the area of mitochondrial function, energy homeostasis and metabolomics has led us to discover a remarkably strong association between adverse cardiometabolic outcomes and tissue/blood levels of acylcarnitine (AC) conjugates. These metabolites derive from acyl-CoA intermediates of fuel catabolism and permit mitochondrial export of excess carbons. For the past decade, our laboratory has remained keenly committed to answering a crucial question: What is this AC signature telling us about the interplay between mitochondria and metabolic disease? The current proposal aims to test the hypothesis that AC accumulation reflects a bottleneck in the fatty acid oxidation (FAO) pathway that diminishes mitochondrial power and efficiency. This prediction stems from unique insights gained via the application of a new mitochondrial diagnostics platform developed by our laboratory during the previous grant cycle. In simple terms, our assays serve as an in vitro “stress test” that evaluates how well a given population of mitochondria, fueled by specific mixtures of carbon substrates, responds to a graded energetic challenge. We have been combining this platform with mass spectrometry-based metabolomics, proteomics and 13C metabolic flux analysis to evaluate mitochondrial remodeling and corresponding changes in respiratory power and efficiency in response to a variety of nutritional and genetic maneuvers. New and exciting findings suggest that AC accumulation reflects a critical thermodynamic vulnerability in the mitochondrial FAO pathway, and thereby serves as a signal of bioenergetic stress, en route to compromised bioenergetics and impending tissue/organ failure. Moreover, our preliminary studies suggest mitochondria resident in untrained skeletal muscles and failing hearts are especially vulnerable to this lipid-induced “traffic jam”; and that ketones are uniquely able to circumvent the roadblock to defend cellular energetics in settings of metabolic stress. Accordingly, we also aim to test the hypothesis that ketone oxidation plays an essential role in permitting the salutary mitochondrial and metabolic adaptations known to occur in response to regimens of intermittent fasting.
期刊论文(28)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1371/journal.pgen.1005599
发表时间: 2015-10
期刊: PLoS genetics
影响因子: 4.5
作者: [Keenan MM, Liu B, Tang X, Wu J, Cyr D, Stevens RD, Ilkayeva O, Huang Z, Tollini LA, Murphy SK, Lucas J, Muoio DM, Kim SY, Chi JT]
通讯作者: Chi JT
DOI: 10.1161/circresaha.120.317293
发表时间: 2020-09-25
期刊: CIRCULATION RESEARCH
影响因子: 20.1
作者: [Davidson, Michael T., Grimsrud, Paul A., Lai, Ling, Draper, James A., Fisher-Wellman, Kelsey H., Narowski, Tara M., Abraham, Dennis M., Koves, Timothy R., Kelly, Daniel P., Muoio, Deborah M.]
通讯作者: Muoio, Deborah M.
DOI: 10.1016/j.celrep.2018.08.091
发表时间: 2018-09-25
期刊: Cell reports
影响因子: 8.8
作者: [Fisher-Wellman KH, Davidson MT, Narowski TM, Lin CT, Koves TR, Muoio DM]
通讯作者: Muoio DM
DOI: 10.2337/db15-0709
发表时间: 2015-09
期刊: Diabetes
影响因子: 7.7
作者: [Huynh FK, Muoio DM, Hirschey MD]
通讯作者: Hirschey MD
14
    FASEB SRC: The Molecular Metabolism Conference: From Cell Biology to Systems Physiology
    STIM1 and metabolic flexibility
    • 批准号:
      9895772
    • 项目类别:
    • 资助金额:
      $57.57万
    • 财政年份:
      2017
    • 负责人:
      DEBORAH M MUOIO
    • 依托单位:
    Role of Carnitine Acetyltransferase in Defending Mitochondrial and Metabolic Func
    • 批准号:
      7977269
    • 项目类别:
    • 资助金额:
      $44.96万
    • 财政年份:
      2010
    • 负责人:
      DEBORAH M MUOIO
    • 依托单位:
    Carnitine Acetyltransferase in Defending Mitochondrial and Metabolic Function
    • 批准号:
      8538370
    • 项目类别:
    • 资助金额:
      $34.08万
    • 财政年份:
      2010
    • 负责人:
      DEBORAH M MUOIO
    • 依托单位:
    海外基金